185 related articles for article (PubMed ID: 28649535)
1. Characterization of the MPS I-H knock-in mouse reveals increased femoral biomechanical integrity with compromised material strength and altered bone geometry.
Oestreich AK; Garcia MR; Yao X; Pfeiffer FM; Nobakhti S; Shefelbine SJ; Wang Y; Brodeur AC; Phillips CL
Mol Genet Metab Rep; 2015 Dec; 5():3-11. PubMed ID: 28649535
[TBL] [Abstract][Full Text] [Related]
2. Characterization of an MPS I-H knock-in mouse that carries a nonsense mutation analogous to the human IDUA-W402X mutation.
Wang D; Shukla C; Liu X; Schoeb TR; Clarke LA; Bedwell DM; Keeling KM
Mol Genet Metab; 2010 Jan; 99(1):62-71. PubMed ID: 19751987
[TBL] [Abstract][Full Text] [Related]
3. The designer aminoglycoside NB84 significantly reduces glycosaminoglycan accumulation associated with MPS I-H in the Idua-W392X mouse.
Wang D; Belakhov V; Kandasamy J; Baasov T; Li SC; Li YT; Bedwell DM; Keeling KM
Mol Genet Metab; 2012 Jan; 105(1):116-25. PubMed ID: 22056610
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic characterisation of the Mucopolysaccharidosis Type I (MPSI) Idua-W392X mouse model reveals increased anxiety-related traits in female mice.
Andreou T; Ishikawa-Learmonth Y; Bigger BW
Mol Genet Metab; 2023 Aug; 139(4):107651. PubMed ID: 37473537
[TBL] [Abstract][Full Text] [Related]
5. Long-term nonsense suppression therapy moderates MPS I-H disease progression.
Gunn G; Dai Y; Du M; Belakhov V; Kandasamy J; Schoeb TR; Baasov T; Bedwell DM; Keeling KM
Mol Genet Metab; 2014 Mar; 111(3):374-381. PubMed ID: 24411223
[TBL] [Abstract][Full Text] [Related]
6. Decreased performance in IDUA knockout mouse mimic limitations of joint function and locomotion in patients with Hurler syndrome.
Kim C; Kwak MJ; Cho SY; Ko AR; Rheey J; Kwon JY; Chung Y; Jin DK
Orphanet J Rare Dis; 2015 Sep; 10():121. PubMed ID: 26407983
[TBL] [Abstract][Full Text] [Related]
7. Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients.
Oussoren E; Keulemans J; van Diggelen OP; Oemardien LF; Timmermans RG; van der Ploeg AT; Ruijter GJ
Mol Genet Metab; 2013 Aug; 109(4):377-81. PubMed ID: 23786846
[TBL] [Abstract][Full Text] [Related]
8. p.X654R IDUA variant among Thai individuals with intermediate mucopolysaccharidosis type I and its residual activity as demonstrated in COS-7 cells.
Ngiwsara L; Ketudat-Cairns JR; Sawangareetrakul P; Charoenwattanasatien R; Champattanachai V; Kuptanon C; Pangkanon S; Tim-Aroon T; Wattanasirichaigoon D; Svasti J
Ann Hum Genet; 2018 May; 82(3):150-157. PubMed ID: 29282708
[TBL] [Abstract][Full Text] [Related]
9. Novel splice site IDUA gene mutation in Tunisian pedigrees with hurler syndrome.
Chkioua L; Boudabous H; Jaballi I; Grissa O; Turkia HB; Tebib N; Laradi S
Diagn Pathol; 2018 May; 13(1):35. PubMed ID: 29843745
[TBL] [Abstract][Full Text] [Related]
10. Gentamicin-mediated suppression of Hurler syndrome stop mutations restores a low level of alpha-L-iduronidase activity and reduces lysosomal glycosaminoglycan accumulation.
Keeling KM; Brooks DA; Hopwood JJ; Li P; Thompson JN; Bedwell DM
Hum Mol Genet; 2001 Feb; 10(3):291-9. PubMed ID: 11159948
[TBL] [Abstract][Full Text] [Related]
11. Identification and molecular characterization of alpha-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy.
Yogalingam G; Guo XH; Muller VJ; Brooks DA; Clements PR; Kakkis ED; Hopwood JJ
Hum Mutat; 2004 Sep; 24(3):199-207. PubMed ID: 15300847
[TBL] [Abstract][Full Text] [Related]
12. Biomechanical and histological characterization of MPS I mice femurs.
Ferreira NY; do Nascimento CC; Pereira VG; de Oliveira F; Medalha CC; da Silva VC; D'Almeida V
Acta Histochem; 2021 Feb; 123(2):151678. PubMed ID: 33434858
[TBL] [Abstract][Full Text] [Related]
13. Identification of an α-l-iduronidase (IDUA) M1T mutation in a Chinese family with autosomal recessive mucopolysaccharidosis I.
Liu D; Jiang Z; Deng L; Li H; Jiang H
Ann N Y Acad Sci; 2023 Aug; 1526(1):114-125. PubMed ID: 37347427
[TBL] [Abstract][Full Text] [Related]
14. Triamterene Functions as an Effective Nonsense Suppression Agent for MPS I-H (Hurler Syndrome).
Siddiqui A; Dundar H; Sharma J; Kaczmarczyk A; Echols J; Dai Y; Sun CR; Du M; Liu Z; Zhao R; Wood T; Sanders S; Rasmussen L; Bostwick JR; Augelli-Szafran C; Suto M; Rowe SM; Bedwell DM; Keeling KM
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901952
[TBL] [Abstract][Full Text] [Related]
15. Transgenic over-expression of plasminogen activator inhibitor-1 results in age-dependent and gender-specific increases in bone strength and mineralization.
Nordstrom SM; Carleton SM; Carson WL; Eren M; Phillips CL; Vaughan DE
Bone; 2007 Dec; 41(6):995-1004. PubMed ID: 17888748
[TBL] [Abstract][Full Text] [Related]
16. Sexual behaviour in a murine model of mucopolysaccharidosis type I (MPS I).
Barbosa Mendes A; do Nascimento CC; D'Almeida V
PLoS One; 2019; 14(12):e0220429. PubMed ID: 31834922
[TBL] [Abstract][Full Text] [Related]
17. alpha-L-iduronidase premature stop codons and potential read-through in mucopolysaccharidosis type I patients.
Hein LK; Bawden M; Muller VJ; Sillence D; Hopwood JJ; Brooks DA
J Mol Biol; 2004 Apr; 338(3):453-62. PubMed ID: 15081804
[TBL] [Abstract][Full Text] [Related]
18. An algorithm to predict phenotypic severity in mucopolysaccharidosis type I in the first month of life.
Kingma SD; Langereis EJ; de Klerk CM; Zoetekouw L; Wagemans T; IJlst L; Wanders RJ; Wijburg FA; van Vlies N
Orphanet J Rare Dis; 2013 Jul; 8():99. PubMed ID: 23837464
[TBL] [Abstract][Full Text] [Related]
19. Evidence that glycosaminoglycan storage and collagen deposition in the cauda epididymidis does not impair sperm viability in the Mucopolysaccharidosis type I mouse model.
do Nascimento CC; Aguiar O; Viana GM; D Almeida V
Reprod Fertil Dev; 2020 Feb; 32(3):304-312. PubMed ID: 31679559
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of the molecular lesion causing mucopolysaccharidosis type I in cats.
He X; Li CM; Simonaro CM; Wan Q; Haskins ME; Desnick RJ; Schuchman EH
Mol Genet Metab; 1999 Jun; 67(2):106-12. PubMed ID: 10356309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
